Potent monoclonal antibody shows promise against emerging SARS-CoV-2 variants of concern

By | April 29, 2021
In a new study currently available on the bioRxiv* preprint server, a group of US-based researchers developed a panel of neutralizing monoclonal antibodies against SARS-CoV-2 that can block viral attachment to cells – and pinpointed a specific one that can potently neutralize all tested variants of concern.